Designing DNA nanodevices for compatibility with the immune system of higher organisms

Nature Nanotechnology

Volumn 10, Issue 9, 2015, Pages 741-747

  Surana, Sunaina ^a   Shenoy, Avinash R ^b   Krishnan, Yamuna ^a,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF AGRICULTURAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL SYSTEMS; IMMUNE SYSTEM; NANOSTRUCTURED MATERIALS; NUCLEIC ACIDS;

DELIVERY DEVICE; HOST RESPONSE; LIVING SYSTEMS; MOLECULAR PROGRAMMING; NANO-DEVICES; RECENT TRENDS; RESPONSE PATHWAYS; SAFETY ISSUES;

DNA;

DNA; NANOMATERIAL; NUCLEIC ACID; RECOMBINANT ANTIBODY; BIOMATERIAL; DRUG CARRIER;

ANTIBODY RESPONSE; BIOCOMPATIBILITY; CELL LINE; DENDRITIC CELL; DNA SEQUENCE; DRUG DELIVERY SYSTEM; DRUG STABILITY; HOMEOSTASIS; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR BIOLOGY; NANODEVICE; NONHUMAN; ORGANISMS; PRIORITY JOURNAL; REVIEW; TISSUE REGENERATION; ANIMAL; DRUG DESIGN; METABOLISM; MOUSE; NANOMEDICINE; PROCEDURES;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL LINE; DNA; DRUG CARRIERS; DRUG DESIGN; HUMANS; IMMUNE SYSTEM; MICE; NANOMEDICINE; NANOSTRUCTURES;

EID: 84941137774     PISSN: 17483387     EISSN: 17483395     Source Type: Journal    
DOI: 10.1038/nnano.2015.180     Document Type: Review

References (102)

1. Jones, M. R.; Seeman, N. C. and Mirkin, C. A. Programmable materials and the nature of the DNA bond. Science 347, 1260901 (2015). We recommend this paper as an introduction to advances in DNA nanotechnology
2. Krishnan, Y. and Bathe, M. Designer nucleic acids to probe and program the cell. Trends Cell Biol. 22, 624-633 (2012)
3. Fu, Y. and He, C. Nucleic acid modifications with epigenetic significance. Curr. Opin. Chem. Biol. 16, 516-524 (2012)
4. Frost, L. S.; Leplae, R.; Summers, A. O. and Toussaint, A. Mobile genetic elements: the agents of open source evolution. Nature Rev. Microbiol. 3, 722-732 (2005)
5. Bickle, T. A. and Krüger, D. H. Biology of DNA restriction. Microbiol. Rev. 57, 434-450 (1993)
6. Makarova, K. S.; Wolf, Y. I. and Koonin, E. V. Comparative genomics of defense systems in archaea and bacteria. Nucleic Acids Res. 41, 4360-4377 (2013)
7. Mao, S.; Sun, W. and Kissel, T. Chitosan-based formulations for delivery of DNA and siRNA. Adv. Drug Deliv. Rev. 62, 12-27 (2010)
8. Xu, C.-X. et al. V-shaped dinuclear Pt(II) complexes: selective interaction with human telomeric G-quadruplex and significant inhibition towards telomerase. Sci. Rep. 3, 2060 (2013)
9. Guéron, M. and Leroy, J. L. The i-motif in nucleic acids. Curr. Opin. Struct. Biol. 10, 326-331 (2000)
10. Cutler, J. I.; Auyeung, E. and Mirkin, C. A. Spherical nucleic acids. J. Am. Chem. Soc. 134, 1376-1391 (2012)
11. Rothemund, P. W. K. Folding DNA to create nanoscale shapes and patterns. Nature 440, 297-302 (2006)
12. Horvath, P. and Barrangou, R. CRISPR/Cas, the immune system of bacteria and archaea. Science 327, 167-70 (2010)
13. Goubau, D.; Deddouche, S. and Reis e Sousa, C. Cytosolic sensing of viruses. Immunity 38, 855-869 (2013)
14. Wu, J. and Chen, Z. J. Innate immune sensing and signaling of cytosolic nucleic acids. Annu. Rev. Immunol. 32, 461-488 (2014). References 13 and 14 provide an overview of the mechanisms of detection of nucleic acids and related immune responses
15. Ivashkiv, L. B. and Donlin, L. T. Regulation of type I interferon responses. Nature Rev. Immunol. 14, 36-49 (2014)
16. Eldridge, M. J. and Shenoy, A. R. Antimicrobial inflammasomes: unified signalling against diverse bacterial pathogens. Curr. Opin. Microbiol. 23, 32-41 (2015)
17. Lupfer, C.; Malik, A. and Kanneganti, T.-D. Inflammasome control of viral infection. Curr. Opin. Virol. 12, 38-46 (2015). Host responses to nucleic acids via the interferon and caspase-1 inflammasome pathways are summarized in refs 15-17
18. Desmet, C. J. and Ishii, K. J. Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination. Nature Rev. Immunol. 12, 479-491 (2012)
19. Holm, C. K.; Paludan, S. R. and Fitzgerald, K. A. DNA recognition in immunity and disease. Curr. Opin. Immunol. 25, 13-18 (2013)
20. Atianand, M. K.; Rathinam, V. A. and Fitzgerald, K. A. SnapShot: inflammasomes. Cell 153, 272-272.e1 (2013)
21. Burdette, D. L. and Vance, R. E. STING and the innate immune response to nucleic acids in the cytosol. Nature Immunol. 14, 19-26 (2013)
22. Sun, L.; Wu, J.; Du, F.; Chen, X. and Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786-791 (2013)
23. Ablasser, A. et al. cGAS produces a 2-5-linked cyclic dinucleotide second messenger that activates STING. Nature 498, 380-384 (2013)
24. Bhat, N. and Fitzgerald, K. A. Recognition of cytosolic DNA by cGAS and other STING-dependent sensors. Eur. J. Immunol. 44, 634-640 (2014)
25. Chiu, Y.-H.; Macmillan, J. B. and Chen, Z. J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138, 576-591 (2009)
26. Yang, P. et al. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a ?-catenin-dependent pathway. Nature Immunol. 11, 487-494 (2010)
27. Wagner, H. The sweetness of the DNA backbone drives Toll-like receptor 9. Curr. Opin. Immunol. 20, 396-400 (2008)
28. Krieg, A. M. Therapeutic potential of Toll-like receptor 9 activation. Nature Rev. Drug Discov. 5, 471-484 (2006). Molecular determinants of TLR9-activating dsDNA and their potential application in vaccine design are discussed in refs 27 and 28
29. Jin, T. et al. Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity 36, 561-571 (2012)
30. Gehrke, N. et al. Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing. Immunity 39, 482-495 (2013)
31. Gilliet, M.; Cao, W. and Liu, Y.-J. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nature Rev. Immunol. 8, 594-606 (2008)
32. Huang, L. et al. Cutting edge: DNA sensing via the STING adaptor in myeloid dendritic cells induces potent tolerogenic responses. J. Immunol. 191, 3509-3513 (2013)
33. Radovic-Moreno, A. F. et al. Immunomodulatory spherical nucleic acids. Proc. Natl Acad. Sci. USA 112, 3892-3897 (2015)
34. Nagata, S. DNA degradation in development and programmed cell death. Annu. Rev. Immunol. 23, 853-875 (2005)
35. Atianand, M. K. and Fitzgerald, K. A. Molecular basis of DNA recognition in the immune system. J. Immunol. 190, 1911-1918 (2013)
36. Lee-Kirsch, M. A. et al. Mutations in the gene encoding the 3?-5? DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nature Genet. 39, 1065-1067 (2007)
37. Crow, Y. J. et al. Mutations in the gene encoding the 3?-5? DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nature Genet. 38, 917-920 (2006)
38. Kawane, K. et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443, 998-1002 (2006)
39. Gall, A. et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36, 120-131 (2012)
40. Stetson, D. B.; Ko, J. S.; Heidmann, T. and Medzhitov, R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134, 587-598 (2008). The importance of DNAses in preventing systemic inflammation is discussed in this study
41. Chitrabamrung, S.; Rubin, R. L. and Tan, E. M. Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol. Int. 1, 55-60 (1981)
42. Martinez Valle, F.; Balada, E.; Ordi-Ros, J. and Vilardell-Tarres, M. DNase 1 and systemic lupus erythematosus. Autoimmun. Rev. 7, 359-363 (2008).
43. Yoshida, H.; Okabe, Y.; Kawane, K.; Fukuyama, H. and Nagata, S. Lethal anemia caused by interferon-? produced in mouse embryos carrying undigested DNA. Nature Immunol. 6, 49-56 (2005).
44. Ahn, J.; Gutman, D.; Saijo, S. and Barber, G. N. STING manifests self DNA-dependent inflammatory disease. Proc. Natl Acad. Sci. USA 109, 19386-19391 (2012).
45. Bhatia, D.; Surana, S.; Chakraborty, S.; Koushika, S. P. and Krishnan, Y. A synthetic icosahedral DNA-based host-cargo complex for functional in vivo imaging. Nature Commun. 2, 339 (2011). The first description of tissue-specific cargo delivery in vivo using a DNA nanodevice.
46. Lee, H. et al. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nature Nanotech. 7, 389-393 (2012). This report describes a DNA nanodevice that delivers RNAi to tumours in vivo.
47. Surana, S.; Bhat, J. M.; Koushika, S. P. and Krishnan, Y. An autonomous DNA nanomachine maps spatiotemporal pH changes in a multicellular living organism. Nature Commun. 2, 340 (2011). The first designer DNA nanodevice that was delivered tissue-specifically in vivo where it functioned as a pH reporter.
48. Surana, S.; Bhatia, D. and Krishnan, Y. A method to study in vivo stability of DNA nanostructures. Methods 64, 94-100 (2013).
49. Antony, A. C. Folate receptors. Annu. Rev. Nutr. 16, 501-521 (1996).
50. Liu, X. et al. A DNA nanostructure platform for directed assembly of synthetic vaccines. Nano Lett. 12, 4254-4259 (2012)
51. Gupta, S. et al. Oral delivery of therapeutic proteins and peptides: a review on recent developments. Drug Deliv. 20, 237-246 (2013)
52. Longmire, M.; Choyke, P. L. and Kobayashi, H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 3, 703-717 (2008)
53. Ali, J. et al. Potential of nanoparticulate drug delivery systems by intranasal administration. Curr. Pharm. Des. 16, 1644-1653 (2010)
54. Dhuria, S. V, Hanson, L. R. and Frey, W. H. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J. Pharm. Sci. 99, 1654-1673 (2010)
55. Harmon, B. T. et al. Intranasal administration of plasmid DNA nanoparticles yields successful transfection and expression of a reporter protein in rat brain. Gene Ther. 21, 514-521 (2014)
56. Ding, X.-Q. et al. Ocular delivery of compacted DNA-nanoparticles does not elicit toxicity in the mouse retina. PLoS One 4, e7410 (2009)
57. Farjo, R.; Skaggs, J.; Quiambao, A. B.; Cooper, M. J. and Naash, M. I. Efficient non-viral ocular gene transfer with compacted DNA nanoparticles. PLoS One 1, e38 (2006)
58. Ziady, A.-G. et al. Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo. Mol. Ther. 8, 936-947 (2003)
59. Yurek, D. M. et al. DNA nanoparticles: detection of long-term transgene activity in brain using bioluminescence imaging. Mol. Imaging 10, 327-339 (2011)
60. Dai, H. et al. Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery. Int. J. Nanomedicine 1, 507-522 (2006)
61. El-Sayed, A. and Harashima, H. Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis. Mol. Ther. 21, 1118-1130 (2013)
62. Arteaga, C. L. and Engelman, J. A. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. Cancer Cell 25, 282-303 (2014)
63. Modi, S.; Nizak, C.; Surana, S.; Halder, S. and Krishnan, Y. Two DNA nanomachines map pH changes along intersecting endocytic pathways inside the same cell. Nature Nanotech. 8, 459-467 (2013)
64. Saha, S.; Prakash, V.; Halder, S.; Chakraborty, K. and Krishnan, Y. A pH-independent DNA nanodevice for quantifying chloride transport in organelles of living cells. Nature Nanotech. 10, 645-651 (2015)
65. Ewert, K. K. et al. Cationic liposome-nucleic acid complexes for gene delivery and silencing: pathways and mechanisms for plasmid DNA and siRNA. Top. Curr. Chem. 296, 191-226 (2010)
66. Doshi, N. and Mitragotri, S. Macrophages recognize size and shape of their targets. PLoS One 5, e10051 (2010)
67. Walsh, A. S.; Yin, H.; Erben, C. M.; Wood, M. J. A. and Turberfield, A. J. DNA cage delivery to mammalian cells. ACS Nano 5, 5427-5432 (2011)
68. Bhatia, D. et al. Icosahedral DNA nanocapsules by modular assembly. Angew. Chem. Int. Ed. 48, 4134-4137 (2009)
69. Millart, H.; Durlach, V. and Durlach, J. Red blood cell magnesium concentrations: analytical problems and significance. Magnes. Res. 8, 65-76 (1995)
70. Sobczak, J.-P. J.; Martin, T. G.; Gerling, T. and Dietz, H. Rapid folding of DNA into nanoscale shapes at constant temperature. Science 338, 1458-1461 (2012)
71. Wei, B.; Dai, M. and Yin, P. Complex shapes self-assembled from single-stranded DNA tiles. Nature 485, 623-626 (2012)
72. Hahn, J.; Wickham, S. F. J.; Shih, W. M. and Perrault, S. D. Addressing the instability of DNA nanostructures in tissue culture. ACS Nano 8, 8765-8775 (2014)
73. Douglas, S. M. et al. Self-assembly of DNA into nanoscale three-dimensional shapes. Nature 459, 414-418 (2009)
74. Liedl, T.; Högberg, B.; Tytell, J.; Ingber, D. E. and Shih, W. M. Self-assembly of three-dimensional prestressed tensegrity structures from DNA. Nature Nanotech. 5, 520-524 (2010)
75. Perrault, S. and Shih, W. Virus-inspired membrane encapsulation of DNA nanostructures to achieve in vivo stability. ACS Nano 8, 5132-5140 (2014)
76. Chen, J. H. and Seeman, N. C. Synthesis from DNA of a molecule with the connectivity of a cube. Nature 350, 631-633 (1991)
77. Keum, J.-W. and Bermudez, H. Enhanced resistance of DNA nanostructures to enzymatic digestion. Chem. Commun. 45, 7036-7038 (2009)
78. Conway, J. W.; McLaughlin, C. K.; Castor, K. J. and Sleiman, H. DNA nanostructure serum stability: greater than the sum of its parts. Chem. Commun. 49, 1172-1174 (2013)
79. Dohno, C.; Okamoto, A. and Saito, I. Stable, specific, and reversible base pairing via Schiff base. J. Am. Chem. Soc. 127, 16681-16684 (2005)
80. Tomás-Gamasa, M.; Serdjukow, S.; Su, M.; Müller, M. and Carell, T. Post-it type connected DNA created with a reversible covalent cross-link. Angew. Chem. Int. Ed. 54, 796-800 (2015)
81. DAlonzo, D.; Guaragna, A. and Palumbo, G. Exploring the role of chirality in nucleic acid recognition. Chem. Biodivers. 8, 373-413 (2011)
82. Hyrup, B. and Nielsen, P. E. Peptide nucleic acids (PNA): synthesis, properties and potential applications. Bioorg. Med. Chem. 4, 5-23 (1996)
83. Leumann, C. J. Sugar modification as a means to increase the biological performance of oligonucleotides. Vol. 50 Nucleic Acids Symp. Series (Oxf). 55-56 (2006)
84. Liu, J. et al. Fabrication of stable and RNase-resistant RNA nanoparticles active in gearing the nanomotors for viral DNA packaging. ACS Nano 5, 237-246 (2011)
85. Uhlmann, E. Peptide nucleic acids (PNA) and PNA-DNA chimeras: from high binding affinity towards biological function. Biol. Chem. 379, 1045-1052 (1998)
86. Lesnik, E. A. and Freier, S. M. Relative thermodynamic stability of DNA, RNA, and DNA:RNA hybrid duplexes: relationship with base composition and structure. Biochemistry 34, 10807-10815 (1995)
87. Owczarzy, R.; You, Y.; Groth, C. L. and Tataurov, A. V. Stability and mismatch discrimination of locked nucleic acid-DNA duplexes. Biochemistry 50, 9352-9367 (2011)
88. Schüller, V. J. et al. Cellular immunostimulation by CpG-sequence-coated DNA origami structures. ACS Nano 5, 9696-9702 (2011)
89. Greenland, J. R. and Letvin, N. L. Chemical adjuvants for plasmid DNA vaccines. Vaccine 25, 3731-3741 (2007)
90. Huang, L. et al. Engineering DNA nanoparticles as immunomodulatory reagents that activate regulatory T cells. J. Immunol. 188, 4913-4920 (2012)
91. Kaminski, J. J. et al. Synthetic oligodeoxynucleotides containing suppressive TTAGGG motifs inhibit AIM2 inflammasome activation. J. Immunol. 191, 3876-3883 (2013). This report identified DNA motifs that could be used to inhibit the AIM2 receptor-dependent inflammatory pathways
92. Engelmann, I. and Pujol, N. Innate immunity in C. elegans. Adv. Exp. Med. Biol. 708, 105-121 (2010)
93. Hoffmann, J. A. The immune response of Drosophila. Nature 426, 33-38 (2003)
94. Novoa, B. and Figueras, A. Current topics in innate immunity II. Advances in experimental medicine and biology 946, 253-275 (2012)
95. Langevin, C. et al. The antiviral innate immune response in fish: evolution and conservation of the IFN system. J. Mol. Biol. 425, 4904-4920 (2013)
96. Douglas, S. M.; Bachelet, I. and Church, G. M. A logic-gated nanorobot for targeted transport of molecular payloads. Science 335, 831-834 (2012). This paper describes a DNA cargo-hold that delivers payloads triggered by molecular logic
97. Zhao, Y. -X. et al. DNA Origami delivery system for cancer therapy with tunable release properties. ACS Nano 6, 8684-8691 (2012)
98. Lee, J. B. et al. Multifunctional nanoarchitectures from DNA-based ABC monomers. Nature Nanotech. 4, 430-436 (2009)
99. Kim, D.-N.; Kilchherr, F.; Dietz, H. and Bathe, M. Quantitative prediction of 3D solution shape and flexibility of nucleic acid nanostructures. Nucleic Acids Res. 40, 2862-2868 (2012)
100. Pan, K. et al. Lattice-free prediction of three-dimensional structure of programmed DNA assemblies. Nature Commun. 5, 5578 (2014)
101. He, Y. et al. Hierarchical self-assembly of DNA into symmetrical supramolecular polyhedra. Nature 452, 198-201 (2013)
102. Goodman, R. P. et al. Rapid chiral assembly of rigid DNA building blocks for molecular nanofabrication. Science 310, 1661-1665 (2005)